Regulatory Pathway Strategy
Define Your Exact Route to the Korean Market.
A wrong classification delays your launch by years.
Korean classification rarely matches Europe or the US. Going in blind—without a verified predicate or a clear MFDS / NECA / HIRA sequence—stalls the launch.
Precise MFDS Classification
Determining the exact product code and regulatory class specific to South Korea. as needed, submitting the official classification request to MFDS.
Predicate Device Identification
Searching and analyzing locally approved equivalent devices to justify your regulatory route.
Multi-Agency Sequencing
Structuring the critical timeline between MFDS/NIDS (Safety/Efficacy clearance), NECA (New Health Technology Assessment), and HIRA (Insurance Reimbursement).
Strategic mapping for predictable market entry.
Senior regulatory experts analyze your product’s intended use, mechanism of action, and claims to define the single most efficient pathway to commercialization.
Profile
Plan
Proven Execution Across Modalities.
Frequently Asked Questions
Answers to common market entry questions.
Total predictability for your decision and plan.
Eliminate hidden costs and regulatory surprises. By defining the exact scope of work upfront with an independent consultancy, your leadership team gains the clarity needed to approve budgets and forecast Korean revenue with confidence.
Speak with a Strategy Director Today